SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001818382-22-000071
Filing Date
2022-06-13
Accepted
2022-06-13 16:05:18
Documents
13
Period of Report
2022-06-09
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K huma-20220609.htm   iXBRL 8-K 47887
  Complete submission text file 0001818382-22-000071.txt   231373

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT huma-20220609.xsd EX-101.SCH 2299
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT huma-20220609_def.xml EX-101.DEF 15922
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT huma-20220609_lab.xml EX-101.LAB 30801
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT huma-20220609_pre.xml EX-101.PRE 16600
7 EXTRACTED XBRL INSTANCE DOCUMENT huma-20220609_htm.xml XML 14583
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Filer) CIK: 0001818382 (see all company filings)

IRS No.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39532 | Film No.: 221011613
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences